Evenity 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification1 
Decision 
Information 
issued on 
Issued2 / 
affected3  
IB/0020 
C.I.z - Changes (Safety/Efficacy) of Human and 
07/08/2023 
Veterinary Medicinal Products - Other variation 
amended 
on 
SmPC, 
Labelling and 
PL 
IB/0019 
B.II.e.7.b - Change in supplier of packaging 
19/06/2023 
n/a 
components or devices (when mentioned in the 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
dossier) - Replacement or addition of a supplier 
N/0017 
Minor change in labelling or package leaflet not 
22/02/2023 
PL 
connected with the SPC (Art. 61.3 Notification) 
PSUSA/10824
Periodic Safety Update EU Single assessment - 
09/02/2023 
n/a 
PRAC Recommendation - maintenance 
/202207 
romosozumab 
IB/0016/G 
This was an application for a group of variations. 
31/10/2022 
n/a 
B.II.z - Quality change - Finished product - Other 
variation 
B.I.z - Quality change - Active substance - Other 
variation 
PSUSA/10824
Periodic Safety Update EU Single assessment - 
01/09/2022 
n/a 
PRAC Recommendation - maintenance 
/202201 
romosozumab 
IB/0014 
B.I.a.4.z - Change to in-process tests or limits 
17/05/2022 
n/a 
applied during the manufacture of the AS - Other 
variation 
II/0010 
C.I.11.b - Introduction of, or change(s) to, the 
07/04/2022 
n/a 
obligations and conditions of a marketing 
authorisation, including the RMP - Implementation of 
change(s) which require to be further substantiated 
by new additional data to be submitted by the MAH 
where significant assessment is required 
PSUSA/10824
Periodic Safety Update EU Single assessment - 
10/02/2022 
n/a 
PRAC Recommendation - maintenance 
/202107 
romosozumab 
Page 2/4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N/0012 
Minor change in labelling or package leaflet not 
29/10/2021 
Labelling and 
connected with the SPC (Art. 61.3 Notification) 
PL 
PSUSA/10824
Periodic Safety Update EU Single assessment - 
02/09/2021 
n/a 
PRAC Recommendation - maintenance 
/202101 
romosozumab 
PSUSA/10824
Periodic Safety Update EU Single assessment - 
11/02/2021 
n/a 
PRAC Recommendation - maintenance 
/202007 
romosozumab 
IA/0008 
B.II.d.2.e - Change in test procedure for the finished 
11/12/2020 
n/a 
product - Update of the test procedure to comply 
with the updated general monograph in the Ph. Eur. 
II/0005 
B.I.b.2.z - Change in test procedure for AS or 
15/10/2020 
n/a 
starting material/reagent/intermediate - Other 
variation 
IB/0006 
B.II.b.5.z - Change to in-process tests or limits 
22/09/2020 
n/a 
applied during the manufacture of the finished 
product - Other variation 
PSUSA/10824
Periodic Safety Update EU Single assessment - 
03/09/2020 
n/a 
PRAC Recommendation - maintenance 
/202001 
romosozumab 
IB/0004 
B.II.b.2.a - Change to importer, batch release 
25/06/2020 
n/a 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
IB/0002 
B.II.c.1.z - Change in the specification parameters 
13/03/2020 
n/a 
Page 3/4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and/or limits of an excipient - Other variation 
IB/0001 
B.IV.1.z - Change of a measuring or administration 
03/02/2020 
n/a 
device - Other variation 
Page 4/4 
 
 
 
 
 
 
 
 
 
 
